Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area.
<h4>Background</h4>The dengue vaccine (Dengvaxia) is only recommended for individuals with prior dengue infection (PDI). This study aimed to perform a serosurvey to inform decision-making for vaccine introduction and identify appropriate target populations. We also evaluated the performa...
Guardado en:
Autores principales: | Umaporn Limothai, Sasipha Tachaboon, Janejira Dinhuzen, Taweewun Hunsawong, Prapapun Ong-Ajchaowlerd, Butsaya Thaisomboonsuk, Stefan Fernandez, Supachoke Trongkamolchai, Mananya Wanpaisitkul, Chatchai Chulapornsiri, Anongrat Tiawilai, Thawat Tiawilai, Terapong Tantawichien, Usa Thisyakorn, Nattachai Srisawat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9738708397ce4e9797391463142bc414 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correlation between reported dengue illness history and seropositivity in rural Thailand.
por: Darunee Buddhari, et al.
Publicado: (2021) -
Cost-effectiveness of dengue vaccination in Puerto Rico.
por: Guido España, et al.
Publicado: (2021) -
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
por: Harun Norshidah, et al.
Publicado: (2021) -
Targets and strategies for vaccine development against dengue viruses
por: Wen-Hung Wang, et al.
Publicado: (2021) -
Cost-effectiveness and budget impact analyses of dengue vaccination in Indonesia.
por: Auliya Abdurrohim Suwantika, et al.
Publicado: (2021)